Jpmorgan Chase & Co »

Mink Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $126 9 14.00
2025-03-31 $258 30 8.62

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Renaissance Technologies
Geode Capital Management
BlackRock
UBS Group
Tower Research Capital
Covestor
Advisor Group Holdings
Morgan Stanley
Northwestern Mutual Wealth Management Company
Game Plan Financial Advisors
Bnp Paribas Arbitrage, Snc
Hartland & Co
Jpmorgan Chase & Co

View all funds holding Mink Therapeutics